# Premarket Power Plays: Stocks Rocket & Roll!

Newsy: Bud Fox's 3 Controversial Stocks of the Day
Published: 2026-05-22T14:01:31.849Z
Source: https://newsyai.com/edition/ef9fa0b1-eedd-4be0-93b7-25b63d8ad3c7
Archive: https://newsyai.com/newsy/bde0e0f6-7fac-4abb-93a8-996b5464e3e9.md

---

**Premarket Prick-Pumps & Biotech Boner Blasts: PCLA PicoCELA Penis-Pump +180%, AKTX Akari KRAS Cock-Up +93%, LFS Leifras Lab-Leap +96%!**

**Premarket futures fizzle**—Dow, S&P, and Nasdaq mixed with crude oil twitching around $102+ (OPEC oil-tease tango). Microcap mystery meat, real-news rockets, and acquisition ass-pumps—**PCLA** wireless wang-wave, **AKTX** KRAS cock-block contender, **LFS** sports sperm-shot—bulls yanking the dong, bears begging for the flush!

### 1) PicoCELA (PCLA): “Wireless Mesh +180% Volume-Vomit” vs “Dilution Dong-Drop Disaster”

**Why it’s loud**  
**PCLA** tech-tumble **+180% to ~$6.30** (mcap ~$40M, vol exploding) on pure premarket penis-pump zero-fresh-catalyst chaos—retail retards dry-humping the mesh mystery meat! Recent preferred shares, charter amendments, and CFO control grants scream “more shares incoming.”

**Bull case (mesh moonshot meat-grinder)**  
Game-changing wireless tech + low-float levitation + degens desperate for the next rocket = $15+ squeeze to riches, ride the retail rocket!

**Bear case (vapor-vol vaporware)**  
History of hype-hangovers, public offerings, and share-shafts + no news nut-bust = sub-$2 scam-sphincter, short the soundless shitshow!

**My take, first principles (tech tease vs dilution dump)**  
Core the code: Absent major catalyst amid microcap mania = **float-frenzy fart primed for dilution dump**. Momentum monkey-business? **$8-15**, **$12C** pump-prick—**P$2** fade-fart.

### 2) Akari Therapeutics (AKTX): “KRAS Synergy +93% Pre-Market Prick-Up” vs “Private Placement Pecker-Block”

**Why it’s loud**  
**AKTX** biotech boner **+93% to ~$9.90** (mcap ~$11M, vol panic-piss) on breakthrough preclinical data showing AKTX-101 synergy with KRAS inhibitors in pancreatic cancer models—plus a fresh $5.5M private placement (dilution dong incoming). Recent 1-for-40 reverse split still fresh in the rearview.

**Bull case (ADC ass-kicker)**  
Pipeline tailwinds + KRAS-mutated cancer potential + sector squeeze = $20+ supernova, ape the asset annihilation!

**Bear case (financing fuckery)**  
Cash-burn crotch-cricket + dilution dong-drop + execution erectile dysfunction + reverse-split ruin = sub-$2 bust-out bust, short the stock!

**My take, first principles (data dopamine vs dilution drain)**  
Strip the stats: Real preclinical signal + low float = **overbaked orgasm orbiting oblivion**. Scalp the spunk, **$12-20**, **$15C** merger-meat—**P$3** trap-tumble.

### 3) Leifras Co. (LFS): “Sports School +96% Acquisition Ass-Blast” vs “Integration Itch”

**Why it’s loud**  
**LFS** education erection **+96% to ~$3.68** (mcap ~$97M, vol exploding) on Tokai Sports acquisition + strong FY2025 results, record revenue/profit growth, and 2026 guidance for double-digit expansion—retail retching the sports sperm-shot!

**Bull case (roll-up rocket)**  
M&A momentum + school partnerships + national policy tailwinds = $8+ dead-cat dong-bounce, dip-buy the dealer’s delight!

**Bear case (acquisition ass-pain)**  
Integration erectile dysfunction + microcap volatility + potential overpay = sub-$2 bust-out bust, short the stock!

**My take, first principles (growth gravy vs execution edge)**  
Boil the books: Legit financials + acquisition catalyst + low float = **rebound from rubble with real runway**. Value vulture? **$5-8**, **$6.50C** bounce-boner—**P$2** miss-morgue.

**Tape-Side Tactics (PCLA PicoCELA Penis-Pump, AKTX Akari KRAS Cock-Up & LFS Leifras Lab-Leap?)**  
- **PCLA**: **$8-15** vol-vomit; **$12C** float-fuck, **P$2** dud-dump.  
- **AKTX**: **$12-20** data-dong; **$15C** synergy-spunk, **P$3** dilution-dump.  
- **LFS**: **$5-8** acquisition-ass; **$6.50C** growth-gravy, **P$2** integration-itch.

Futures foreskin-flay amid crude cock-up, micro-madness or earnings echo? Balls-deep DYOR, NFA, degens duck the dilutions!

**Sources** (for tracking every claim above):  
- Premarket movers & % changes: Benzinga, StockAnalysis.com, MarketChameleon (May 22, 2026 data).[[1]](https://stockanalysis.com/markets/premarket/)[[2]](https://www.benzinga.com/premarket)  
- PCLA details & filings: Yahoo Finance, TipRanks (May 2026).  
- AKTX preclinical data & financing: Company press releases via RTTNews, GlobeNewswire (May 21-22, 2026).[[3]](https://www.rttnews.com/3654769/akari-shares-surge-in-pre-market-on-breakthrough-data-showing-synergy-kras-inhibition.aspx)  
- LFS acquisition & results: PR Newswire, StockTitan (May 2026).  
- Volatility rankings & tickers: Investing.com, TradingView pre-market scans (May 2026).
